These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 21147765)

  • 41. RAD51 protein expression is increased in canine mammary carcinomas.
    Klopfleisch R; Schütze M; Gruber AD
    Vet Pathol; 2010 Jan; 47(1):98-101. PubMed ID: 20080488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p63: a novel myoepithelial cell marker in canine mammary tissues.
    Gama A; Alves A; Gartner F; Schmitt F
    Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased Derlin-1 expression in metastases of canine mammary adenocarcinomas.
    Klopfleisch R; Schütze M; Linzmann H; Brunnberg L; Gruber AD
    J Comp Pathol; 2010 Jan; 142(1):79-83. PubMed ID: 19632687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical assay for detecting estrogen receptors in canine mammary tumors.
    Graham JC; O'Keefe DA; Gelberg HB
    Am J Vet Res; 1999 May; 60(5):627-30. PubMed ID: 10328435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calreticulin expression in neoplastic versus normal dog mammary glands: a cDNA subtraction-based study.
    Okawa T; Kurio Y; Morimoto M; Hayashi T; Nakagawa T; Sasaki N; Okuda M; Mizuno T
    Res Vet Sci; 2012 Feb; 92(1):80-91. PubMed ID: 21126744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer.
    Klopfleisch R; Hvid H; Klose P; da Costa A; Gruber AD
    Vet Comp Oncol; 2010 Dec; 8(4):293-301. PubMed ID: 21062411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.
    Ferreira E; Gobbi H; Saraiva BS; Cassali GD
    Vet Pathol; 2012 Mar; 49(2):322-9. PubMed ID: 21282668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas.
    Klopfleisch R; Gruber AD
    Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
    Amorim I; Lopes CC; Faustino AM; Pereira PD
    J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.
    de Araújo MR; Campos LC; Ferreira E; Cassali GD
    J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantification of VEGF-C expression in canine mammary tumours.
    Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
    Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation, purification, culture and characterisation of myoepithelial cells from normal and neoplastic canine mammary glands using a magnetic-activated cell sorting separation system.
    Sánchez-Céspedes R; Maniscalco L; Iussich S; Martignani E; Guil-Luna S; De Maria R; Martín de Las Mulas J; Millán Y
    Vet J; 2013 Aug; 197(2):474-82. PubMed ID: 23583698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
    Klopfleisch R; Gruber AD
    J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear pleomorphism: role in grading and prognosis of canine mammary carcinomas.
    Santos M; Correia-Gomes C; Santos A; de Matos A; Rocha E; Lopes C; Pereira PD
    Vet J; 2014 Jun; 200(3):426-33. PubMed ID: 24745769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of immunohistochemical markers of lymphatic and blood vessels in canine mammary tumours.
    Sleeckx N; Van Brantegem L; Fransen E; Van den Eynden G; Casteleyn C; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2013 May; 148(4):307-17. PubMed ID: 23123127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The lymph drainage of the neoplastic mammary glands in the bitch: a lymphographic study.
    Patsikas MN; Karayannopoulou M; Kaldrymidoy E; Papazoglou LG; Papadopoulou PL; Tzegas SI; Tziris NE; Kaitzis DG; Dimitriadis AS; Dessiris AK
    Anat Histol Embryol; 2006 Aug; 35(4):228-34. PubMed ID: 16836586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer.
    Clemente M; Pérez-Alenza MD; Illera JC; Peña L
    Vet Pathol; 2010 Mar; 47(2):265-74. PubMed ID: 20106772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
    Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
    Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemical detection of P-glycoprotein (clone C494) in canine mammary gland tumours.
    Petterino C; Rossetti E; Bertoncello D; Martini M; Zappulli V; Bargelloni L; Castagnaro M
    J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):174-8. PubMed ID: 16629950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased presence of stromal myofibroblasts and tenascin-C with malignant progression in canine mammary tumors.
    Yoshimura H; Michishita M; Ohkusu-Tsukada K; Takahashi K
    Vet Pathol; 2011 Jan; 48(1):313-21. PubMed ID: 20571146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.